Cancer/Oncology Drugs Market
According to Intent Market Research, the Cancer Drugs Market is expected to grow from USD 203.5 billion in 2023 at a CAGR of 13.1% to touch USD 482.0 billion by 2030. The Cancer Drugs Market is dominated by key players such as Roche Holding AG, Novartis International AG, Bristol Myers Squibb, Merck & Co., Inc., AstraZeneca PLC, Pfizer Inc., Eli Lilly and Co., Johnson & Johnson, Sanofi S.A., AbbVie Inc., GlaxoSmithKline PLC, Amgen Inc., Gilead Sciences, Inc., Boehringer Ingelheim GmbH, Bayer AG.